News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
228 Results
Type
Article (22)
Press Release (206)
Section
Business (89)
Deals (23)
Drug Development (13)
FDA (1)
Job Trends (2)
News (107)
Policy (4)
Tag
Academia (3)
Alliances (11)
Approvals (1)
Best Places to Work (1)
Cancer (1)
Clinical research (10)
COVID-19 (1)
Diagnostics (16)
Earnings (45)
Events (50)
FDA (1)
Government (2)
Healthcare (6)
Infectious disease (1)
Intellectual property (1)
IPO (21)
Job creations (1)
Manufacturing (1)
Medical device (1)
Medtech (1)
Mergers & acquisitions (2)
NextGen: Class of 2026 (1)
Non-profit (2)
Pancreatic cancer (1)
People (31)
Phase 1 (7)
Phase 2 (5)
Phase 3 (6)
Pipeline (1)
Preclinical (4)
Real estate (2)
Regulatory (4)
Research institute (1)
Date
Last 365 days (1)
2025 (1)
2024 (11)
2023 (26)
2022 (41)
2021 (43)
2020 (49)
2019 (21)
2018 (16)
2017 (7)
2016 (7)
2015 (6)
Location
Asia (8)
Australia (1)
Europe (217)
North Carolina (1)
Ohio (1)
South America (1)
United States (2)
228 Results for "immunovia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM
September 23, 2025
·
4 min read
Immunovia publishes the annual report for 2023
Immunovia AB announced that the Annual Report for 2023 has been published.
April 29, 2024
·
1 min read
Business
Immunovia announces updated financial calendar - April 22, 2024
Immunovia updates its financial calendar for 2024.
April 22, 2024
·
1 min read
Business
Immunovia appoints Dr. Lisa Ford as Clinical Laboratory Director
Immunovia today announces the appointment of Dr. Lisa Ford as Clinical Laboratory Director.
April 29, 2024
·
2 min read
Business
Immunovia announces updated financial calendar - March 12, 2024
Immunovia updates its financial calendar for 2024.
March 12, 2024
·
1 min read
Business
Immunovia Publishes Interim Report for January-March 2024
On April 9, the Company announced that Immunovia had successfully developed accurate and precise assays to measure targeted proteins for its next-generation test.
April 29, 2024
·
8 min read
Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
Immunovia announces that the company will move its lab and U.S. headquarters to Research Triangle Park in North Carolina in May 2024.
April 29, 2024
·
2 min read
Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
Immunovia announces its next-generation pancreatic cancer test achieved both the primary and secondary endpoints in a model-development study.
April 22, 2024
·
4 min read
Immunovia announces financial calendar for financial year 2024
Immunovia, a diagnostic company with the vision to revolutionize blood-based diagnostics and survival rates for patients with cancer, announces its financial calendar for 2024.
January 4, 2024
·
1 min read
Business
Immunovia appoints Norma Alonzo Palma as new Vice President of Clinical and Medical Affairs
Immunovia announces the appointment of Norma Alonzo Palma, PhD as Vice President of Clinical and Medical Affairs.
January 31, 2024
·
2 min read
1 of 23
Next
